# A China RWS to Evaluate the Effectiveness and Safety of Perampanel as an add-on Treatment for Epileptic Seizure

> **NCT05257915** · — · UNKNOWN · sponsor: **Beijing Children's Hospital** · enrollment: 600 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Perampanel

## Key facts

- **NCT ID:** NCT05257915
- **Lead sponsor:** Beijing Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-01
- **Primary completion:** 2021-10-31
- **Final completion:** 2022-06-30
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2022-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05257915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05257915, "A China RWS to Evaluate the Effectiveness and Safety of Perampanel as an add-on Treatment for Epileptic Seizure". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05257915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*